Guangping Li Selected Research

Alloxan

1/2018	Xanthine Oxidase Inhibitor Allopurinol Prevents Oxidative Stress-Mediated Atrial Remodeling in Alloxan-Induced Diabetes Mellitus Rabbits.
10/2017	Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits.
5/2017	Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits.
10/2016	NADPH oxidase inhibitor apocynin prevents atrial remodeling in alloxan-induced diabetic rabbits.
2/2015	Probucol prevents atrial remodeling by inhibiting oxidative stress and TNF-α/NF-κB/TGF-β signal transduction pathway in alloxan-induced diabetic rabbits.
8/2014	Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits.
1/2013	Impaired atrial electromechanical function and atrial fibrillation promotion in alloxan-induced diabetic rabbits.
11/2012	Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guangping Li Research Topics

Disease

77	Atrial Fibrillation 06/2022 - 01/2005
32	Atrial Remodeling 09/2022 - 04/2008
30	Fibrosis (Cirrhosis) 12/2022 - 06/2010
13	Heart Failure 12/2022 - 04/2008
12	Inflammation (Inflammations) 12/2021 - 08/2008
11	Atherosclerosis 04/2022 - 02/2009
11	Tachycardia (Tachyarrhythmias) 01/2018 - 06/2010
10	Hypoxia (Hypoxemia) 09/2022 - 06/2018
10	Myocardial Infarction 01/2021 - 11/2009
9	Diabetes Mellitus 05/2021 - 01/2013
7	Hypertension (High Blood Pressure) 01/2021 - 01/2011
6	Neoplasms (Cancer) 01/2021 - 07/2008
5	Mitochondrial Diseases (Mitochondrial Disease) 10/2021 - 01/2017
5	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 02/2009
4	Necrosis 12/2022 - 12/2016
4	Myocardial Ischemia (Ischemic Heart Diseases) 07/2022 - 12/2016
4	Sepsis (Septicemia) 01/2022 - 01/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 01/2019
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2011
4	Thrombosis (Thrombus) 01/2020 - 05/2014
4	Acute Coronary Syndrome 01/2020 - 07/2013
4	Stroke (Strokes) 01/2020 - 01/2017
3	Ventricular Tachycardia 06/2022 - 10/2017
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022 - 01/2017
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2008
3	Hypertrophy 01/2022 - 10/2016
3	Hyperglycemia 11/2020 - 11/2012
3	Cardiac Arrhythmias (Arrythmia) 01/2020 - 05/2008
3	Atherosclerotic Plaque (Atheroma) 01/2020 - 08/2017
3	Chronic Renal Insufficiency 06/2016 - 11/2009
2	Reperfusion Injury 07/2022 - 12/2016
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 10/2016
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2021 - 11/2007
2	Osteosarcoma (Osteogenic Sarcoma) 07/2021 - 08/2020
2	Essential Hypertension 01/2021 - 10/2015

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2022 - 04/2016
8	AlloxanIBA 01/2018 - 11/2012
8	angiotensin I (1-7)IBA 01/2018 - 06/2010
8	AntioxidantsIBA 07/2013 - 08/2008
6	Ion Channels (Ion Channel)IBA 09/2022 - 07/2009
6	oxidized low density lipoproteinIBA 04/2022 - 01/2011
6	SodiumIBA 01/2022 - 10/2014
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 10/2013
6	Pioglitazone (Actos)FDA Link 01/2021 - 04/2008
6	LipidsIBA 08/2020 - 02/2009
6	Probucol (Lorelco)FDA Link 02/2019 - 02/2009
5	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022 - 11/2015
5	Messenger RNA (mRNA)IBA 01/2022 - 06/2010
5	CollagenIBA 09/2021 - 08/2014
5	C-Reactive ProteinIBA 01/2021 - 04/2007
5	salicylhydroxamic acid (SHAM)IBA 01/2021 - 06/2010
5	TicagrelorIBA 12/2020 - 08/2015
5	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2011
4	CalciumIBA 07/2022 - 01/2018
4	Pharmaceutical PreparationsIBA 06/2022 - 02/2009
4	Apolipoproteins E (ApoE)IBA 04/2022 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2019
4	Valsartan (Vals)FDA Link 09/2021 - 12/2018
4	NADP (NADPH)IBA 05/2021 - 11/2015
4	aliskiren FDA Link 01/2021 - 04/2014
4	Fluvastatin FDA Link 12/2020 - 06/2014
4	Caspase 3 (Caspase-3)IBA 01/2020 - 08/2017
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2019 - 08/2014
4	ThiazolidinedionesIBA 01/2017 - 08/2008
4	Anti-Arrhythmia AgentsIBA 06/2016 - 07/2009
3	Atrial Natriuretic Factor (ANF)IBA 12/2022 - 12/2015
3	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2019
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 01/2019
3	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 01/2019
3	Histones (Histone)IBA 01/2022 - 10/2016
3	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2021 - 10/2016
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2011
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 01/2020
3	Uric Acid (Urate)IBA 01/2021 - 01/2011
3	Galectin 3 (LGALS3)IBA 01/2021 - 03/2020
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021 - 08/2018
3	Angiotensin Receptor AntagonistsIBA 10/2020 - 10/2006
3	Biological ProductsIBA 09/2020 - 08/2018
3	Cilostazol (Pletal)FDA LinkGeneric 05/2020 - 01/2016
3	Doxycycline (Periostat)FDA LinkGeneric 01/2020 - 06/2018
3	wenxin keliIBA 01/2020 - 01/2016
3	Therapeutic UsesIBA 03/2019 - 01/2018
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2014 - 05/2008
2	ImmunosorbentsIBA 12/2022 - 01/2011
2	Interleukin-6 (Interleukin 6)IBA 12/2022 - 05/2014
2	EnzymesIBA 12/2022 - 01/2011
2	Nicorandil (SG 75)IBA 07/2022 - 01/2020
2	Interleukin-18 (Interleukin 18)IBA 06/2022 - 08/2016
2	Vitamin D FDA LinkGeneric 01/2022 - 09/2016
2	AcidsIBA 12/2021 - 12/2016
2	Durapatite (Hydroxylapatite)IBA 07/2021 - 08/2020
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 12/2018
2	IvabradineIBA 01/2021 - 11/2016
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
2	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 01/2020

Therapy/Procedure

16	Therapeutics 06/2022 - 11/2007
9	Percutaneous Coronary Intervention 01/2020 - 01/2005
8	Catheter Ablation 06/2021 - 01/2011
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 12/2009
3	Electric Countershock (Cardioversion) 01/2017 - 04/2007